AI Article Synopsis

  • Carbonic anhydrase-IX (CAIX) is evaluated as a prognostic biomarker in high-risk nonmetastatic clear cell renal cell carcinoma (ccRCC), amid mixed evidence regarding its reliability.
  • A study involving 813 patients from the ARISER trial analyzed CAIX expression and its correlation with lymphatic spread and survival using a scoring system based on staining intensity and percentage of positive cells.
  • Results indicate that while a high CAIX expression (>85%) was not a significant predictor of disease-free or overall survival, a CAIX score of 200 or higher was linked to improved survival outcomes, suggesting that CAIX score should be routinely assessed in high-risk ccRCC patients post-surgery.

Article Abstract

Introduction And Objective: With a limited number of prognostic and predictive biomarkers available, carbonic anhydrase-IX (CAIX) has served as an important prognostic biomarker for patients with clear cell renal cell carcinoma (ccRCC). However, studies have recently called into question the role of CAIX as a biomarker for ccRCC. To investigate this uncertainty, we quantified the association of CAIX with lymphatic involvement and survival using data from ARISER study (WX-2007-03-HR)--a prospective trial involving subjects with high-risk nonmetastatic ccRCC.

Methods And Materials: We reviewed the records of 813 patients enrolled in the ARISER study. Central review of histology, grade, and CAIX staining (frequency and intensity) was performed. CAIX score was derived by multiplying the staining intensity (1-3) by percent positive cells (0%-100%), yielding a range of 0 to 300. We quantified the association of CAIX expression and score with lymphatic spread and survival (disease-free survival [DFS] and overall survival [OS]) using Kaplan-Meier and multivariable propensity score adjusted Cox regression analyses.

Results: Median follow-up of the cohort was 54.2 months. Although 56% of subjects with lymphatic involvement had CAIX>85%, only 33% had CAIX score ≥ 200. On multivariable analysis, CAIX>85% was not a statistically significant predictor of DFS and OS (P = 0.06 and P = 0.15, respectively). However, CAIX score ≥ 200, when compared with CAIX score ≤ 100, was associated with improved DFS and OS (P = 0.01 and P = 0.01, respectively) on multivariable analysis.

Conclusions: The largest, multicenter, prospective analysis of patients with high-risk nonmetastatic ccRCC demonstrates the utility of CAIX score as a statistically significant prognostic biomarker for survival. We recommend that CAIX score be quantified for all patients with high-risk disease after nephrectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.02.013DOI Listing

Publication Analysis

Top Keywords

caix score
24
high-risk nonmetastatic
12
caix
11
score
9
carbonic anhydrase-ix
8
renal cell
8
cell carcinoma
8
prognostic biomarker
8
quantified association
8
association caix
8

Similar Publications

Anatomic imaging with contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) has long been the mainstay of renal mass characterization. However, those modalities are often unable to adequately characterize indeterminate, solid, enhancing renal masses - with some exceptions, such as the development of the clear-cell likelihood score on multi-parametric MRI. As such, molecular imaging approaches have gained traction as an alternative to anatomic imaging.

View Article and Find Full Text PDF

The aim of this longitudinal descriptive observational study was to analyze the influence of different lifestyles on arterial stiffness (AS) throughout five years of follow-up and to describe the differences by sex in a Spanish adult population without cardiovascular disease at the start of the study. A random stratified sampling by age and sex was used to obtain 501 subjects included in the initial assessment. No cardiovascular disease was allowed in the subjects.

View Article and Find Full Text PDF

Colorectal liver metastases that survive radioembolization display features of aggressive tumor behavior.

HPB (Oxford)

November 2023

Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands. Electronic address:

Article Synopsis
  • Radiation lobectomy is a treatment that uses targeted radiation to help shrink liver tumors and grow healthy liver tissue.
  • In a study, researchers looked at patients with colorectal liver cancer and found that the amount of radiation didn't clearly affect the tumor's response.
  • They discovered that tumors with certain markers, like higher levels of a growth marker (Ki-67) and cancer stem cells (Olfm4), were less likely to shrink, highlighting that some cancer cells are tough and need quick surgery after radiation treatment.
View Article and Find Full Text PDF

Background: Hypoxic microenvironment is prominent in advanced esophageal squamous cell carcinoma (ESCC). However, it is unclear whether ESCC becomes hypoxic when it remains in the mucosal layer or as it invades the submucosal layer. We aimed to investigate whether intramucosal (Tis-T1a) or submucosal invasive (T1b) ESCC becomes hypoxic using endoscopic submucosal dissection samples.

View Article and Find Full Text PDF
Article Synopsis
  • In head and neck squamous cell carcinoma, tumor hypoxia is linked to resistance to treatment and poor outcomes, while HPV-positive patients tend to have better responses and survival rates.
  • A study focused on patients with squamous cell carcinoma of the nasal cavity and sinuses assessed the expression of hypoxia-related proteins and their correlation with HPV status and overall survival.
  • Results showed high expression of CA-IX as a potential negative prognostic indicator, while no significant correlation was found between HPV status and the expression of hypoxia markers.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!